PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation

BACKGROUND: Colorectal cancer (CRC) is one of the most common malignancies, and it’s expected that the CRC burden will substantially increase in the next two decades. New biomarkers for targeted treatment and associated molecular mechanism of tumorigenesis remain to be explored. In this study, we in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaojuan, Wu, Fan, Wang, Han, Duan, Xiaoyuan, Huang, Rong, Tuersuntuoheti, Amannisa, Su, Luying, Yan, Shida, Zhao, Yuechao, Lu, Yan, Li, Kai, Yao, Jinjie, Luo, Zhiwen, Guo, Lei, Liu, Jianmei, Chen, Xiao, Lu, Yalan, Hu, Hanjie, Li, Xingchen, Bao, Mandula, Bi, Xinyu, Du, Boyu, Miao, Shiying, Cai, Jianqiang, Wang, Linfang, Zhou, Haitao, Ying, Jianming, Song, Wei, Zhao, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398064/
https://www.ncbi.nlm.nih.gov/pubmed/32746883
http://dx.doi.org/10.1186/s13046-020-01632-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398064/
https://www.ncbi.nlm.nih.gov/pubmed/32746883
http://dx.doi.org/10.1186/s13046-020-01632-9

Ejemplares similares